Bank Of America Corp Pulse Biosciences, Inc. Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 782,584 shares of PLSE stock, worth $11.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

782,584

Previous 779,552 0.39%

Holding current value

$11.4 Million

Previous $6.79 Million 28.99%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$6.69 - $14.54 $20,284 - $44,085	3,032 Added 0.39%	782,584 $8.76 Million
Q1 2024 May 15, 2024	SELL	$7.8 - $11.02 $169,954 - $240,114	-21,789 Reduced 2.72%	779,552 $6.79 Million
Q4 2023 Feb 14, 2024	BUY	$3.85 - $12.84 $72,510 - $241,828	18,834 Added 2.41%	801,341 $9.81 Million
Q2 2023 Aug 14, 2023	BUY	$3.67 - $8.64 $35,866 - $84,438	9,773 Added 1.26%	782,507 $5.63 Million
Q1 2023 May 12, 2023	BUY	$2.48 - $3.88 $9,905 - $15,496	3,994 Added 0.52%	772,734 $2.6 Million
Q4 2022 Feb 10, 2023	SELL	$1.73 - $2.89 $965 - $1,612	-558 Reduced 0.07%	768,740 $2.13 Million
Q3 2022 Nov 14, 2022	BUY	$1.23 - $2.3 $239 - $448	195 Added 0.03%	769,298 $1.77 Million
Q2 2022 Aug 12, 2022	SELL	$1.48 - $4.28 $75,904 - $219,508	-51,287 Reduced 6.25%	769,103 $1.18 Million
Q1 2022 May 16, 2022	BUY	$4.21 - $14.79 $166,905 - $586,349	39,645 Added 5.08%	820,390 $3.99 Million
Q4 2021 Feb 08, 2022	BUY	$14.78 - $24.4 $85,546 - $141,227	5,788 Added 0.75%	780,745 $11.6 Million
Q3 2021 Nov 15, 2021	BUY	$17.25 - $26.63 $13.1 Million - $20.2 Million	758,622 Added 4644.15%	774,957 $16.7 Million
Q2 2021 Sep 13, 2021	BUY	$16.31 - $23.64 $266,423 - $386,159	16,335 New	16,335 $268,000

Others Institutions Holding PLSE

# of Institutions

Shares Held

4.8M

Call Options Held

138K

Put Options Held

96.2K

View Full List

About Pulse Biosciences, Inc.

Ticker PLSE
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 37,125,900
Market Cap $541M
Description
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...

More about PLSE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Pulse Biosciences, Inc. Transaction History